Medical Weight Loss for Miami, Florida Residents
Miami, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Miami through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Miami Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Miami, Florida residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Miami, with one of the largest Hispanic communities in the country, is served through telehealth from our Costa Mesa, California clinic, in both English and Spanish, by secure video.
Patients across Miami and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Florida. We care for patients throughout Downtown, Brickell, Little Havana, Coral Gables, Coconut Grove, and the greater Miami metro. Whether you are starting your first GLP-1 program or switching from a brand medication, your Miami treatment plan is built around your health history and goals.
Our telehealth model serves Miami and communities across Florida with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Miami patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Miami patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Miami
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Miami address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Miami
Does New Hope Weight Loss treat patients in Miami?
Yes. Although the clinic is in Costa Mesa, California, we treat Miami, Florida residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Miami?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Miami address in cold-pack packaging.
What do Miami patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Miami do you serve?
We serve patients from across Miami by telehealth, including Downtown, Brickell, Little Havana, Coral Gables, Coconut Grove, and the greater Miami metro.
Is bilingual care available for Miami patients?
Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles Spanish-language calls, WhatsApp, and consultations for Miami patients, with Dr. Sharma supervising every case clinically. The full telehealth program is available in Spanish.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Miami, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.